South Korea Digestive Health Habits Keep Demand for Everyday Remedies Steady
Digestive remedies remain an established part of South Korea’s consumer healthcare landscape, supported by routine demand for relief from indigestion, heartburn, bloating, and other common digestive discomforts. According to the latest analysis by Vyansa Intelligence, the South Korea digestive remedies industry was valued at USD 155 million in 2025 and is projected to reach USD 175 million by 2032, representing a 1.75% CAGR from 2026 to 2032. The industry is estimated to reach USD 160 million in 2026.
Fast-Paced Eating Habits Support Everyday Demand
South Korea’s fast-paced lifestyle continues to support demand for digestive remedies. The Vyansa Intelligence analysis identifies frequent consumption of quick meals, eating out, overeating, and irregular eating schedules as important factors behind recurring digestive discomfort. These habits can contribute to indigestion, bloating, fullness, and acid reflux, creating consistent demand for familiar products that provide quick symptom relief.
The report also points to household spending patterns as an indication of continued food-related consumption. During the first quarter of 2025, spending on food and non-alcoholic beverages in the home increased year over year, while spending at restaurants and hotels also recorded growth. Continued expenditure across these categories supports the relevance of products used for post-meal digestive discomfort.
This creates a relatively stable demand environment. Rather than depending solely on occasional purchases, digestive remedies can benefit from consumers’ recurring need for convenient relief following meals or irregular eating occasions.
Indigestion and Heartburn Remedies Dominate
Indigestion and heartburn remedies accounted for approximately 70% of the industry in 2025, making them the leading product segment in South Korea. The category includes antacids, antiflatulents, digestive enzymes, H2 blockers, and proton pump inhibitors.
The strong position of this segment reflects the routine nature of indigestion-related complaints and consumers’ familiarity with established remedies. In a mature industry where breakthrough innovation is relatively limited, fast and trusted relief remains an important purchasing consideration.
Other product categories covered by the industry include diarrhoeal remedies, IBS treatments, laxatives, motion-sickness remedies, and paediatric digestive remedies. However, the substantial share held by indigestion and heartburn products demonstrates their central role in the country’s digestive-remedy landscape.
Offline Retail Remains the Primary Purchasing Route
Retail offline channels represented approximately 60% of sales in 2025, according to the Vyansa Intelligence analysis. Pharmacies, hospitals, and clinics remain important points of access, with physical stores benefiting from consumer trust, immediate availability, and pharmacist guidance.
This is particularly relevant for digestive remedies because consumers may seek products when symptoms occur and therefore value immediate access. Familiar brands available through established pharmacies can also encourage repeat purchasing.
Digital commerce is nevertheless expanding rapidly in South Korea. Mobile shopping transaction values reached KRW 17.0339 trillion in June 2025, according to the report, with mobile transactions accounting for 77.8% of online shopping value. Despite this digital expansion, digestive remedies continue to retain a strong offline presence.
Cross-Border Shopping Creates Pricing Pressure
One of the industry’s key challenges is increasing price competition from international shopping. The Vyansa Intelligence analysis notes that consumers can compare prices online and purchase lower-priced alternatives from overseas sources when product differentiation is limited. This creates difficulties for local companies and imported brands attempting to maintain premium pricing.
The report cites Statistics Korea data showing that South Korea’s online overseas direct purchases totaled KRW 2.1762 trillion in the second quarter of 2025, representing a 5.6% year-over-year increase. Purchases from China accounted for KRW 1.4660 trillion during the period, making it the largest regional source.
For digestive-remedy companies, this environment increases the importance of competitive pricing, brand trust, product differentiation, and effective distribution.
Wellness-Oriented Products Are Gaining Attention
Consumer preferences are gradually expanding beyond traditional symptom-relief products. The Vyansa Intelligence analysis identifies a growing preference for lighter, natural, and wellness-focused digestive solutions, particularly among younger consumers.
Enzyme-based and supplement-style products containing ingredients such as papain and bromelain are highlighted as examples of alternatives gaining interest. These products appeal to consumers looking for digestive-health solutions that can fit into everyday wellness routines rather than being used exclusively after significant discomfort occurs.
This shift does not eliminate demand for conventional remedies. Instead, it broadens the competitive landscape by creating opportunities for products positioned around preventive digestive care, lifestyle compatibility, and gentler daily use.
Convenience Stores Present an Expansion Opportunity
Convenience-store distribution represents an important potential opportunity for the industry. The Vyansa Intelligence report notes that only a limited range of OTC medicines can currently be sold outside pharmacies, while certain digestive aids are already part of the broader self-care environment. Expanding access to eligible digestive products through convenience stores could improve visibility and support impulse purchases for mild digestive discomfort.
The potential is supported by South Korea’s extensive convenience-store network. Statistics Korea’s preliminary 2024 Franchise Survey found that convenience stores represented 17.5% of all franchise establishments, the largest share among franchise business types.
For a mature category growing at a relatively modest pace, even incremental expansion into convenient retail locations could provide companies with additional opportunities for trial and repeat purchases.
Regulatory Framework Supports Controlled Access
South Korea’s Ministry of Food and Drug Safety (MFDS) maintains a specific regulatory framework for medicines and quasi-drugs. The ministry identifies digestive remedies intended to improve digestive health among quasi-drugs when they meet the applicable manufacturing standards, including certain liquid products for internal use.
The MFDS also maintains official systems for drug and quasi-drug information and certificate verification, supporting regulatory oversight and consumer access to product information.
This regulatory structure is important for companies operating in the category because product classification, manufacturing standards, and permitted sales channels can influence how digestive remedies reach consumers.
Competition Remains Stable and Brand-Focused
More than 15 companies are actively involved in producing digestive remedies in South Korea, while the top five companies accounted for approximately 45% of industry share in 2025, according to Vyansa Intelligence. The report identifies Daewoong Pharmaceutical, Handok, Sam Sung Pharmaceutical, Dong Wha Pharmaceutical Industrial, and Boehringer Ingelheim Korea among the leading participants.
The competitive environment is characterized by established brands, strong consumer familiarity, pricing strategies, and incremental product development rather than major disruptive innovation. Dong Wha Pharmaceutical, for example, benefits from long-standing consumer recognition of its Gas Whalmyungsoo-Q brand, while other companies are using product extensions and herbal-based formulations to differentiate themselves.
Imported brands are also adjusting pricing strategies in response to cross-border purchasing pressures, adding another layer to competition.
Outlook for Digestive Remedies in South Korea
The relatively modest growth rate reflects the mature nature of the category, but stable everyday demand provides an important foundation. Fast meals, eating out, irregular eating patterns, and recurring digestive discomfort continue to support conventional indigestion and heartburn remedies.
At the same time, wellness-focused products, enzyme-based supplements, and expanded convenience-store access create opportunities for companies seeking incremental growth. Pricing pressure from overseas purchasing and online comparison will remain an important challenge.
Overall, the South Korean digestive-remedies industry is evolving through gradual shifts in consumer habits, retail access, pricing, and wellness preferences rather than rapid structural disruption. Established remedies remain central to the category, while emerging lifestyle-oriented products and alternative retail channels can provide additional avenues for future development.